Ligand Pharmaceuticals, Inc. (NASDAQ:LGND)
CAPS Rating:
Develops and markets new drugs that address critical unmet medical needs in the areas of cancer, mens and womens health, skin diseases, osteoporosis, and metabolic, cardiovascular and inflammatory diseases.
RSS Headlines
Fool UK
Recs
jimmy boy did make a recommendation, the stock has been running with the bulls